Effect of prostanoids on the coronary circulation
After the discovery of prostacyclin (PGI2) (Moncada et al., 1976) the pronounced biological actions of this compound led to a number of different hypotheses concerning its role in various physiological and pathophysiological states. Due to its continuous formation in the vascular endothelium throughout the systemic and pulmonary circulatory systems the platelet anti-aggregatory effect of PGI2 was considered to balance the pro-aggregatory effect of thromboxane A2 (TxA2) (Gryglewski et al., 1976). The vasodilator action of PGI2 was also considered to be of significance in the local regulation of blood flow in various tissues, especially in the coronary circulation. The expectations on an important role of PGI2 in coronary physiology were based not only on the coronary relaxant effect of the compound observed in studies on isolated coronary vessels from various species, including man, but also on studies on inhibition of prostaglandin (PG) formation in various animal in vivo models.
KeywordsPlacebo Catheter Aspirin Adenosine Prostaglandin
Unable to display preview. Download preview PDF.
- ALEXANDER, R.W., KENT, K.M., PISANO, J.J., KEISER, H.R. & COOPER, T. (1975). Regulation of postocclusive hyperemia by endogenously synthesized prostaglandins in the dog heart. J. din. Invest., 55, 1174–1181.Google Scholar
- GORDON, J.L. & MARTIN, W. (1982). Responses of porcine aortic endothelial cells to vasodilator agents. Proc. Physiol. Soc., 45P–46P.Google Scholar
- KRAEMER, R.J., PHERNETTON, T.M. & FOLTS, J.D. (1976). Prostaglandin-like substances in coronary venous blood following myocardial ischemia. J. Pharmac. exp. Ther., 199, 611–619.Google Scholar